Patents by Inventor Venkatakrishna Shyamala

Venkatakrishna Shyamala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reagents, methods, and systems for detecting methicillin-resistant
    Patent number: 8735554
    Abstract: The present invention provides PBP2a peptide antigens for generating antibodies against MRSA, and provides high-affinity binding agents that detect MRSA by selective immunoreactivity with PBP2a. The antibodies are useful in methods and systems for detecting MRSA, including biosensor systems, or as components of diagnostic or detection kits. The antibodies, in some embodiments, have therapeutic value against MRSA infection.
    Type: Grant
    Filed: May 7, 2009
    Date of Patent: May 27, 2014
    Assignee: Innovative Biosensors, Inc.
    Inventors: Colette Cote, Qiao-xi Zheng, Venkatakrishna Shyamala, Tom Hazel
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile Virus
    Patent number: 8551706
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: October 8, 2013
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Venkatakrishna Shyamala
  • Identification of Oligonucleotides for the Capture, Detection and Quantitation of Hepatitis A Viral Nucleic Acid
    Publication number: 20120219941
    Abstract: Hepatitis A virus-specific primers and probes derived from conserved regions of the hepatitis A virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: November 21, 2011
    Publication date: August 30, 2012
    Inventor: Venkatakrishna Shyamala
  • Identification of Oligonucleotides for the Capture, Detection and Quantitation of West Nile Virus
    Publication number: 20120015345
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: April 15, 2011
    Publication date: January 19, 2012
    Inventor: Venkatakrishna Shyamala
  • REAGENTS, METHODS, AND SYSTEMS FOR DETECTING METHICILLIN-RESISTANT STAPHYLOCOCCUS
    Publication number: 20110250202
    Abstract: The present invention provides PBP2a peptide antigens for generating antibodies against MRSA, and provides high-affinity binding agents that detect MRSA by selective immunoreactivity with PBP2a. The antibodies are useful in methods and systems for detecting MRSA, including biosensor systems, or as components of diagnostic or detection kits. The antibodies, in some embodiments, have therapeutic value against MRSA infection.
    Type: Application
    Filed: May 7, 2009
    Publication date: October 13, 2011
    Applicant: Innovative Biosensors, Inc.
    Inventors: Colette Cote, Qiao-Xi Zheng, Venkatakrishna Shyamala, Tom Hazel
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Patent number: 7927839
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: April 19, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Venkatakrishna Shyamala
  • HX2004-6 polypeptide expressed in cancerous cells
    Patent number: 7867731
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: January 11, 2011
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventors: Christoph Reinhard, Anne Bennett Jefferson, Vivien W. Chan, Joerg Kaufmann, Hong Xin, Giulia C. Kennedy, Greg Harrowe, Hamiduddin Khoja, Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Patent number: 7833758
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: November 16, 2010
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Patent number: 7807813
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: October 5, 2010
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Publication number: 20070238086
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: October 20, 2006
    Publication date: October 11, 2007
    Applicant: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Publication number: 20070128638
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: October 20, 2006
    Publication date: June 7, 2007
    Inventor: Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Publication number: 20070128637
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: October 20, 2006
    Publication date: June 7, 2007
    Inventor: Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Patent number: 7132233
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: November 7, 2006
    Assignee: Novartis Vaccines and Diagnostics, Inc.
    Inventor: Venkatakrishna Shyamala
  • Diagnostic assays for parvovirus B19
    Publication number: 20050221300
    Abstract: Human parvovirus B19 primers and probes derived from conserved regions of the parvovirus B19 genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes.
    Type: Application
    Filed: May 23, 2005
    Publication date: October 6, 2005
    Applicant: Chiron Corporation
    Inventors: Sergio Pichuantes, Venkatakrishna Shyamala
  • Diagnostic assays for parvovirus B19
    Patent number: 6936442
    Abstract: Human parvovirus B19 primers and probes derived from conserved regions of the parvovirus B19 genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes.
    Type: Grant
    Filed: June 28, 2002
    Date of Patent: August 30, 2005
    Assignee: Chiron Corporation
    Inventors: Sergio Pichuantes, Venkatakrishna Shyamala
  • Gene products differentially expressed in cancerous cells and their methods of use V
    Publication number: 20050130926
    Abstract: The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
    Type: Application
    Filed: October 28, 2004
    Publication date: June 16, 2005
    Inventors: Christoph Reinhard, Anne Jefferson, Vivien Chan, Joerg Kaufmann, Hong Xin, Giulia Kennedy, Greg Harrowe, Hamiduddin Khoja, Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
    Publication number: 20050032729
    Abstract: West Nile virus capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: December 5, 2003
    Publication date: February 10, 2005
    Inventor: Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of hepatitis A viral nucleic acid
    Publication number: 20040072150
    Abstract: Hepatitis A virus-specific primers and probes derived from conserved regions of the hepatitis A virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: June 12, 2003
    Publication date: April 15, 2004
    Inventor: Venkatakrishna Shyamala
  • Diagnostic assays for parvovirus B19
    Publication number: 20030170612
    Abstract: Human parvovirus B19 primers and probes derived from conserved regions of the parvovirus B19 genome are disclosed. Also disclosed are nucleic acid-based assays using the primers and probes.
    Type: Application
    Filed: June 28, 2002
    Publication date: September 11, 2003
    Inventors: Sergio Pichuantes, Venkatakrishna Shyamala
  • Identification of oligonucleotides for the capture, detection and quantitation of hepatitis B viral DNA
    Publication number: 20030143527
    Abstract: Hepatitis B virus capture oligonucleotides, primers and probes derived from conserved regions of the hepatitis B virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
    Type: Application
    Filed: October 9, 2002
    Publication date: July 31, 2003
    Inventor: Venkatakrishna Shyamala